STOP HIV/AIDS

Seek and treat to optimize HIV and AIDS prevention

Since 1996, highly active antiretroviral therapy (HAART) has transformed HIV into a chronic, manageable condition. HAART fully suppresses HIV replication, driving the HIV load in plasma to undetectable levels. This allows for immune reconstitution, long-term remission and dramatic reductions in morbidity and death. Today, a 20-year-old who receives a diagnosis of HIV and treatment with

Seek and treat to optimize HIV and AIDS prevention Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below